Jing Si Herbal Tea as Adjuvant Treatment in Patients With Chronic Pelvic Pain Syndrome
Not yet recruitingNot applicableNCT07357142
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this clinical trial is to evaluate the efficacy of Jing Si Herbal Tea as an adjuvant treatment for patients diagnosed with Chronic Pelvic Pain Syndrome (CPPS). The study aims to determine whether adding Jing Si Herbal Tea to standard care can improve clinical symptoms and quality of life in these patients.
Study details
- Official title
- JING SI HERBAL TEA Use as Adjuvant Treatment in Patients With Chronic Pelvic Pain Syndrome
- Conditions
- Chronic Pelvic Pain Syndrome (CPPS)
- Interventions
- Dietary supplement: Jing Si Herbal Tea
- Other: Placebo
- Sponsor
- Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
- Start date
- 2026-03-01
- Primary completion
- 2029-12-31
- Sex
- Male
- Age range
- from 18 Years to 100 Years
- Results posted
- No results posted in this snapshot
- Countries
- Taiwan
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Male patients. 2. Diagnosed with Chronic Pelvic Pain Syndrome (CPPS) at the investigational site. 3. Currently receiving continuous follow-up and medical treatment. Exclusion Criteria: 1. Female patients (Excluded because the standard treatment, alpha-blockers, is not approved or reimbursed by the National Health Insurance for this indication in women in Taiwan). 2. Duration of symptoms less than 3 months. 3. History of recurrent urinary tract infections. 4. Diagnosed with malignancy. 5. Hospitalization for other diseases within the past 3 months. 6. Unwilling to participate in the study.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07357142